HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FTC Drops Hammer On Skin-Care Sellers For Deceptive 'Risk-Free' Trials

This article was originally published in The Rose Sheet

Executive Summary

A California district court has issued a temporary restraining order in response to FTC's complaint citing seven individuals and a "maze of interrelated shell companies" for deceptive "risk-free" skin-care trial offers. Buried in fine print on the companies' websites were terms specifying how very unfree the trials would be for unsuspecting consumers, FTC says, seeking a permanent injunction and consumer refunds.

You may also be interested in...

California Bill For Tighter Auto-Enroll Controls Could Make Consumers Think Twice

A proposed bill advancing through California's legislature would require businesses to present consumers with a standalone opt-in form for auto-enrollment programs that is separate from the consent mechanism for an introductory gift or offer, and then with written notice three to seven days before the first automatic payment goes through. California's rules for continuity marketing are already the toughest in the nation.

FTC Wins Around $73M From Defendants Behind ‘Risk-Free’ Skin-Care Trials

A California district court has imposed injunctions and monetary penalties on roughly 30 companies and individuals that cooperated to sell AuraVie, Dellure and LéOR Skincare offerings, among others, via deceptive “risk-free” trial plans, according to FTC. The agency says it will continue to go after negative-option billing schemes that charge consumers for recurring product shipments without their express consent.

FTC Prioritizes Health Claims, Disclosures Enforcement In Coming Year

In a presentation at the National Advertising Division Annual Conference, FTC Chairwoman Edith Ramirez discussed the commission’s priorities for the year ahead. Health claims and inadequate disclosures top the list following related settlements with advertisers in 2013 and the agency’s Operation Full Disclosure initiative.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts